Human parvovirus 4 infection, Cameroon

Emerg Infect Dis. 2012 Apr;18(4):680-3. doi: 10.3201/eid1804.110628.

Abstract

In a post hoc analysis of samples collected in 2009, we determined seroprevalence of parvovirus 4 (PARV4) among elderly Cameroonians. PARV4 seropositivity was associated with receipt of intravenous antimalarial drugs, intramuscular streptomycin, or an intramuscular contraceptive, but not hepatitis C virus seropositivity. Findings suggest parenteral acquisition of some PARV4 infections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cameroon / epidemiology
  • Cohort Studies
  • Coinfection / epidemiology*
  • Coinfection / immunology
  • Coinfection / virology
  • Female
  • Hepatitis C / epidemiology*
  • Hepatitis C / immunology
  • Hepatitis C / virology
  • Humans
  • Injections / adverse effects
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Parvoviridae Infections / epidemiology*
  • Parvoviridae Infections / immunology
  • Parvoviridae Infections / virology
  • Parvovirus / immunology*
  • Prevalence
  • Seroepidemiologic Studies